149 related articles for article (PubMed ID: 1796046)
1. Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small intestine of the rat.
Lundin S; Pantzar N; Broeders A; Ohlin M; Weström BR
Pharm Res; 1991 Oct; 8(10):1274-80. PubMed ID: 1796046
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of vasopressin, oxytocin and their analogues [Mpa1, D-Arg8]-vasopressin (dDAVP) and [Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in human kidney and liver homogenates.
Fjellestad-Paulsen A; Lundin S
Regul Pept; 1996 Nov; 67(1):27-32. PubMed ID: 8952002
[TBL] [Abstract][Full Text] [Related]
3. In vitro intestinal transport of vasopressin and its analogues.
Vilhardt H; Lundin S
Acta Physiol Scand; 1986 Apr; 126(4):601-7. PubMed ID: 3716836
[TBL] [Abstract][Full Text] [Related]
4. Receptors for neurohypophyseal hormones along the rat nephron: 125I-labelled d(CH2)5[Tyr(Me)2, Thr4, Orn8, Tyr-NH(2)9] vasotocin binding in microdissected tubules.
Ammar A; Schmidt A; Semmekrot B; Roseau S; Butlen D
Pflugers Arch; 1991 Apr; 418(3):220-7. PubMed ID: 1830390
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat.
Lundin S; Folkesson HG; Pierzynovski SG; Bengtsson HI
Peptides; 1994; 15(5):809-14. PubMed ID: 7984498
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract.
Fjellestad-Paulsen A; Söderberg-Ahlm C; Lundin S
Peptides; 1995; 16(6):1141-7. PubMed ID: 8532599
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
Lundin S; Broeders A; Ohlin M; Hansson K; Bengtsson HI; Trojnar J; Melin P
J Pharmacol Exp Ther; 1993 Feb; 264(2):783-8. PubMed ID: 8437126
[TBL] [Abstract][Full Text] [Related]
8. Absorption of an oxytocin antagonist (antocin) and a vasopressin analogue (dDAVP) through a standardized skin erosion in volunteers.
Lundin S; Svedman P; Höglund P; Jönsson K; Broeders A; Melin P
Pharm Res; 1995 Dec; 12(12):2024-9. PubMed ID: 8786983
[TBL] [Abstract][Full Text] [Related]
9. Different properties of the paracellular pathway account for the regional small intestinal permeability to the peptide desmopressin.
Pantzar N; Lundin S; Weström BR
J Pharm Sci; 1995 Oct; 84(10):1245-8. PubMed ID: 8801342
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties of the tocolytic agent [Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in healthy volunteers.
Lundin S; Broeders A; Melin P
Clin Endocrinol (Oxf); 1993 Sep; 39(3):369-74. PubMed ID: 8222299
[TBL] [Abstract][Full Text] [Related]
12. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
13. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
[TBL] [Abstract][Full Text] [Related]
14. The effects of [Arg8]vasopressin and [Arg8]vasotocin on the firing rate of suprachiasmatic neurons in vitro.
Mihai R; Coculescu M; Wakerley JB; Ingram CD
Neuroscience; 1994 Oct; 62(3):783-92. PubMed ID: 7870306
[TBL] [Abstract][Full Text] [Related]
15. Antagonists for the human oxytocin receptor: an in vitro study.
Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
[TBL] [Abstract][Full Text] [Related]
16. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxytocin receptor antagonists on the renal actions of oxytocin and vasopressin in the rat.
Windle RJ; Judah JM; Forsling ML
J Endocrinol; 1997 Feb; 152(2):257-64. PubMed ID: 9071983
[TBL] [Abstract][Full Text] [Related]
18. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
19. Labelling of vasopressin and oxytocin receptors from the human uterus.
Tence M; Guillon G; Bottari S; Jard S
Eur J Pharmacol; 1990 Dec; 191(3):427-36. PubMed ID: 1964909
[TBL] [Abstract][Full Text] [Related]
20. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
